Disclaimer - You are required to read this before proceeding

Whilst the Aspergillus Website & the Fungal Research Trust have taken every precaution in compiling this site, neither it nor any contributors or charity Trustees can be held responsible for using the information held herein. Medical information changes constantly and the information presented here should not be considered complete or exhaustive and should not be relied upon as the sole or primary source on which to base diagnosis or treatment for any individual.

This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through this site and links to other sites, the Aspergillus Website provides general information for educational purposes only. The information provided in this site, or through links to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call, consultation or the advice of your physician or other healthcare provider.

Neither The Aspergillus Website nor the FRT is liable or responsible for any advice, course of treatment, diagnosis or any other information, services or product you obtain through this site.

I have read this, proceed to the article

Oesophageal aspergillosis

Oesophageal aspergillosis is predominantly seen in patients with leukaemia. It is commonly found at autopsy as part of disseminated aspergillosis, often with symptoms unrecorded during life (Young, 1970: Meyer, 1973; Kami, 2002). Localised oesophageal disease has also been described, but is rare (Yoo, 1995; Choi, 1997; Chionh, 2005). The oesophagus may also be involved by direct spread from pulmonary aspergillosis, with the development of a bronchoesophageal or tracheooesophageal fistula (Mineur, 1985; Kapelushnik, 1994). Direct extension from the oesophagus to the trachea (Obrecht, 1984), heart (Komanduri, 2002) and aorta (Nakamura, 1992) has also been reported.

Where ante-mortem diagnosis is made, patients typically present with odynophagia, epigastric pain or dysphagia. Haematemesis has also been reported (Meyer, 1973). Endoscopically either ulcers (Choi, 1997; Alioglu, 2007) or masses within the oesophagus (Asanza, 2000; Chinoh, 2005) are seen, and microscopic examination of biopsy or brushings reveals the typical dichotomously branching hyphae of Aspergillus. Co-infection with Candida or herpes simplex virus may occur (Obrecht, 1984; Asanza, 2000; Komanduri, 2002).

Treatment follows that of other forms of invasive aspergillosis, and cure has been reported in isolated oesophageal disease (Yoo, 1995; Choi, 1997; Chionh, 2005). Complicating oesophageal stenosis may respond to balloon dilatation (Alioglu, 2007). Successful surgical treatment of a tracheooesophageal fistula due to aspergillosis has also been recorded (Stack, 1997). There is one report of Aspergillus oesophagitis resolving without treatment, in a patient without immunodeficiency being treated for pneumonia (Murata, 1984).

Dr Adam Jeans

Department of Infectious Diseases and Tropical Medicine, Pennine Acute Hospitals NHS Trust,
North Manchester General Hospital,
Manchester, UK
adam.jeans@doctors.org.uk

March 2008

Index References


Disclaimer | Privacy/Confidentiality | Cookies | Terms and Conditions | Advertising
This page was created by Adam Jeans on April 14 2008
This page was last modified: June 09 2011 11:26:03.
Maintained by Aspergillus Website Team